Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-23-033216

Chief Commercial Officer sold 5,199 shares at an average $90.04 ($468,103)

  • Chief Commercial Officer acquired 2,974 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-13 Exercise or conversion : show line 1 in the form +2,974 $16.14 $48,000 17,349 D
2023-07-13 Sale : show line 2 in the form −2,974 $90.05 $267,809 14,375 D
2023-07-13 Sale : show line 3 in the form −2,225 $90.02 $200,295 14,776 I
Open-market sales · 5,199 sh · avg $90.04 · $468,103

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-13 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −2,974 21,249 D
Loading xslF345X05/ownership.xml…